David Cha

David Cha serves as a Clinical Trial Manager at BioAtla, Inc., focusing on oncology with a Phase I/II study for solid tumors since October 2023. Previously, David held roles as Clinical Trial Manager and Senior Clinical Trial Specialist at Pardes Biosciences, leading the ClinOps early development for the PBI-0451 clinical program targeting SARS-CoV-2 from November 2021 to April 2023. Prior experience includes positions at Jazz Pharmaceuticals, Clovis Oncology, Myovant Sciences, Genentech, Stemcentrx, Gilead Sciences, and Ardea Biosciences, covering various roles in clinical trial management, coordination, and quality assurance across multiple therapeutic areas. David earned a Bachelor of Arts degree from UC San Diego in June 2011.